Valuation
- Market cap
- 141,000
- Revenue TTM
- $0
- Net income TTM
- $-250,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 5,989,900
- Avg volume
- 15,091,056
- Day's range
- $0.00 – $0.00
- Shares out
- 1,411,796,000
- Stochastic %K
- 100%
- Beta
- 4.00
- Analysts
- —
- Price target
- —
Company profile
Fifty 1 Labs, Inc., a biotechnology and life sciences company, which focuses on peptide products, peptide discovery, AI-enabled research, and clinical development in the United States. The company provides sports supplements; peptides; telepath products, as well as health and wellness solutions. It offers supplements such as, pre-workout formulas, BCAAS, ION+ electrolyte formula, turmeric gummies, and ashwagandha gum...
Show more
Fifty 1 Labs, Inc., a biotechnology and life sciences company, which focuses on peptide products, peptide discovery, AI-enabled research, and clinical development in the United States. The company provides sports supplements; peptides; telepath products, as well as health and wellness solutions. It offers supplements such as, pre-workout formulas, BCAAS, ION+ electrolyte formula, turmeric gummies, and ashwagandha gummies. The company was formerly known as Consumer Automotive Finance, Inc. and changed its name to Fifty 1 Labs, Inc. in March 2025. Fifty 1 Labs, Inc. was incorporated in 1998 and is based in Vancouver, Canada.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 877 505 5006
- Website
- https://fifty1labs.com
- Address
- 1505 W 2nd Ave, Suite 506, Vancouver, Canada
Latest news
No headlines yet.
